[{"id":"2fb170a4-c1bb-478b-9a26-3efad1e342ff","acronym":"ARYA-2","url":"https://clinicaltrials.gov/study/NCT04634357","created_at":"2022-04-24T10:00:30.724Z","updated_at":"2024-07-02T16:35:15.791Z","phase":"Phase 1/2","brief_title":"ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma","source_id_and_acronym":"NCT04634357 - ARYA-2","lead_sponsor":"Eureka Therapeutics Inc.","biomarkers":" AFP","pipe":"","alterations":" ","tags":["AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ET140203"],"overall_status":"Recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 07/19/2022","start_date":" 07/19/2022","primary_txt":" Primary completion: 01/31/2026","primary_completion_date":" 01/31/2026","study_txt":" Completion: 01/31/2028","study_completion_date":" 01/31/2028","last_update_posted":"2024-03-07"}]